
Rome Therapeutics
ROME Therapeutics develops innovative therapies for cancer and autoimmune diseases using uncharted genetic material.
- 64
- Company
- Boston, MA, USUnited States
Rome Therapeutics is dedicated to developing innovative therapies for cancer and autoimmune diseases by harnessing the power of the repeatome, vast stretches of uncharted genetic material previously dismissed as "junk DNA." The company's mission is to unlock the therapeutic potential of these genetic regions to address unmet medical needs.
Rome Therapeutics has made significant strides in the biotech industry, leveraging cutting-edge research to pioneer new treatments. Their work has garnered attention for its novel approach and potential to revolutionize disease treatment. Notable investors include ARCH Venture Partners and Partners Innovation Fund.
Similar Companies

Kurome Therapeutics
Triplet Therapeutics
triplettx.com

Remix Therapeutics
remixtx.com

CAMP4 Therapeutics
camp4tx.com

LTZ Therapeutics

Trethera
trethera.com

Boundless Bio
boundlessbio.com

Redona Therapeutics
redonatx.com

Raze Therapeutics
razetx.com

Celsius Therapeutics
celsiustx.com

RootPath Genomics
rootpath.com

Immunitas Therapeutics
immunitastx.com

ReviR Therapeutics
revirtx.com

Cartesian Therapeutics

Replay
replay.bio

Palm Therapeutics
Nuon Therapeutics

Immunome

Cyclo Therapeutics

Empire Biotechnologies
Quick Facts
Who are Rome Therapeutics' competitors?
Companies similar to Rome Therapeutics include Kurome Therapeutics, Triplet Therapeutics, Remix Therapeutics and CAMP4 Therapeutics.
When was Rome Therapeutics founded?
Rome Therapeutics was founded in 2020.
Where is Rome Therapeutics' headquarters located?
Rome Therapeutics' headquarters is located in Boston, MA, US.
When was Rome Therapeutics' last funding round?
Rome Therapeutics' most recent funding round was for $72M (USD) in September 2023.
How much disclosed funding has Rome Therapeutics raised?
As of Sep 12, 2023, Rome Therapeutics has disclosed funding of $199M (USD). Undisclosed round amounts are excluded.
How many employees does Rome Therapeutics have?
Rome Therapeutics has 64 employees as of Feb 5, 2024.
Classification
- Ownership
- Technology
- Geographic Exposure
- Customer
- Main Product
- Tags
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8730Research, Development, And Testing Services
- 8731Commercial Physical and Biological Research
- Industry
- —Biotechnology Companies
- —Medical Organizations
- —Pharmaceutical Companies
Show 12 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 620000Health Care and Social Assistance
- 325000Chemical Manufacturing
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 2800Chemicals And Allied Products
- 8000Health Services
- 2830Drugs
- 8040Offices And Clinics Of Other Health Practitioners
- 2834Pharmaceutical Preparations
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified